A Randomized, Masked, Placebo-Controlled Study of Darbepoetin Alfa in Preterm Infants

BACKGROUND: A novel erythropoiesis stimulating agent (ESA), darbepoetin alfa (Darbe), increases hematocrit in anemic adults when administered every 1 to 3 weeks. Weekly Darbe dosing has not been evaluated in preterm infants. We hypothesized that infants would respond to Darbe by decreasing transfusi...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Ohls, Robin K., Christensen, Robert D., Kamath-Rayne, Beena D., Rosenberg, Adam, Wiedmeier, Susan E., Roohi, Mahshid, Lacy, Conra Backstrom, Lambert, Diane K., Burnett, Jill J., Pruckler, Barbara, Schrader, Ron, Lowe, Jean R.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: American Academy of Pediatrics 2013
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3691539/
https://ncbi.nlm.nih.gov/pubmed/23776118
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1542/peds.2013-0143
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller